FTC Urged to Back Provider Status Legislation

Published Online: Thursday, May 8, 2014
Follow Pharmacy_Times:

May 8, 2014-- NACDS and a national coalition working to achieve “provider status” for pharmacists under Medicare Part B have asked the Federal Trade Commission (FTC) to back legislation to this effect, as well as other policies that would help pharmacists practice at the top of their education level.

NACDS and the Patient Access to Pharmacists’ Care Coalition submitted separate yet complementary comments to the FTC as a follow-up to the Commission’s “Examining Healthcare Competition” workshop, which was held March 20-21 to study activities and trends that may affect competition in the evolving healthcare industry.

“Pharmacies remain committed to their valuable role in providing medications, fostering medication safety and effectiveness, and providing health and wellness services. In addition, innovative pharmacy services and other healthcare services available in accessible retail settings can do even more to improve patient health and wellness, often in collaboration with primary care physicians, nurses and other professionals,” NACDS wrote in its comments.

“NACDS supports efforts by the FTC to create a robust healthcare marketplace that advances patient choice and competition to improve the accessibility, quality and affordability of healthcare in America. To that end, NACDS asks FTC to support the removal of needless barriers to the effective functioning of innovative healthcare delivery for the patients we seek to serve; support fairer scope of practice, supervision and reimbursement laws across states to advance competition and patient choice; and support federal legislation that would designate pharmacists as healthcare providers under Medicare Part B, removing an unwarranted and harmful exclusionary, competition barrier.”

Meanwhile, the Coalition wrote in its comments, “A number of factors will combine to create excess demand and a shortage of primary healthcare providers in the near future. The factors include an aging population, a rise in chronic conditions, and policy changes such as those associated with the Affordable Care Act. Patient demand and the resulting problems associated with a lack of access to care are particularly acute in medically underserved areas. To address this increase in demand, all providers in the healthcare system should practice to the fullest extent allowed by their license.”

The FTC fosters competition in healthcare markets to benefit consumers through cost-containment, quality improvement and fostering innovation. The Commission views its role as an enforcer of laws to prevent entities from engaging in anticompetitive conduct that harms consumers; to advise market participants on compliance with antitrust laws; to develop research and reports on competition issues in healthcare; and to advise federal and state governments on competition issues in healthcare.

More information about the FTC’s engagement in healthcare competition is available on the FTC website.
Related Articles
Pharmacists are getting closer to obtaining provider status, as federal legislation that would enable pharmacists to provide health care services to Medicare patients in underserved communities has been reintroduced in the US Senate and House of Representatives.
Bipartisan legislation introduced in the U.S. House of Representatives today would formally designate pharmacists as healthcare providers under Medicare Part B. Supported by the National Association of Chain Drug Stores, the bill would amend The Social Security Act of 1935 to enable pharmacists to provide to Medicare patients in underserved communities services that pharmacists already are providing for other patients under state law.
Emphasizing the importance of promoting policies that improve patient outcomes and lead to healthier, safer communities, the National Association of Chain Drug Stores submitted a statement to the U.S. House Committee on Energy and Commerce Subcommittee on Health in lead-up to today’s hearing titled “Examining Public Health Legislation to Help Patients and Local Communities.”
In support of pharmacy refill reminder programs and other healthcare communications by pharmacies, the National Association of Chain Drug Stores recently filed comments with the Federal Communications Commission requesting regulatory clarification regarding prior consent for calls to consumers’ cell phones for healthcare notifications.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times